DEBRIX Trademark
Serial Number: 79397304 • Registration: 7838964
DEBRIX is a trademark filed by
DEBx Medical B.V.
on April 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Megan Bradshaw Pirkey Barber PLLC
1801 East 6th Street, Suite 300
Austin, TX 78702
United States
Trademark Details
Filing Date
April 5, 2024
Registration Date
June 24, 2025
Published for Opposition
May 6, 2025
Goods & Services
Antiseptic preparations for wound care, namely anti-adhesion gels for use with wound drainage devices
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 21, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 21, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 12, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 24, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 24, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 18, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2024 REPR
